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Abstract
This article forms the second part of the series on the role of lifestyle modification in general practice with specific reference to chronic 
cardiovascular disease. Whilst the major risk factors which constitute an unhealthy lifestyle were discussed in part 1of this series, the 
focus of part 2 will give specific practical guidelines which the general practitioner may incorporate into their practice when counselling 
patients with chronic cardiovascular disease. 
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Introduction
It is apparent that the lifestyle choices of physical inactivity, smoking, 
poor diet and neglect of chronic life-stress, play major roles in the 
pathogenesis of cardiovascular disease. In-depth discussion regarding 
smoking cessation is beyond the scope of this article and guidelines 
can be found elsewhere.1-6  The focus of this article will concentrate on 
physical activity guidelines and basic principles of lifestyle interventions 
with respect to dietary and stress management.
Physical inactivity
It is evident that many patients with chronic cardiac disease should 
undertake regular physical exercise instead of prolonged bed rest.  
Indeed, there are truly very few contraindications to participation 
in some form of regular physical exercise. Whilst patients who are 
counselled merely to “walk as much as possible” as exercise 
management after cardiac disease are perhaps better off than doing 
no exercise whatsoever, often the exercise prescription is ineffective 
or patients become non-compliant. It is for this reason that exercise is 
most effectively delivered through a supervised exercise rehabilitation 
programme that incorporates not only exercise training but also dietary 
management, psychological support, therapeutic education and 
vigorous risk-factor modification. Thus chronic disease rehabilitation 
services are comprehensive programmes designed for delivery of 
secondary prevention; to limit the physiological and psychological 
effects of cardiovascular disease, control cardiac symptoms and 
reduce the risk of subsequent events by stabilising or partially 
reversing the underlying atherosclerosis process.
A secondary prevention or rehabilitation programme may include 
patients who have had coronary artery disease, myocardial infarction, 
heart failure, bypass surgery, pacemaker implantation, cardiac 
transplantation, valve replacement, coronary angioplasty with or 
without stent placement, or who have other evidence of cardiovascular 
disease (including a positive stress test), angina pectoris or 
other evidence of disease from a radionuclide study or coronary 
catheterisation.
Two recent meta-analyses have shown that the evidence behind 
the use of cardiac rehabilitation in the management of patients with 
coronary heart disease (CHD) is strong.7,8 Indeed exercise-based 
cardiac rehabilitation reduced all cause mortality by 20% and reduced 
cardiac mortality by 26%. Furthermore there is a strong positive effect 
of physical exercise training on pathogenesis of the disease, symptoms 
specific to the pathology, physical fitness and strength and quality of 
life.8
However, prescribing exercise for patients with chronic disease can 
be complex.  The objective is to decrease physiological limitations 
and improve physical capacity through specific exercise therapy.  The 
major dilemmas are not in determining which exercise therapies to use 
but in defining goals and choosing the appropriate training intensity, 
duration and frequency.  It is important that the practitioner advises 
the appropriate exercise prescription for the appropriate stage of the 
disease and disability.
Physiological mechanisms whereby exercise training is effective 
in the secondary prevention of cardiovascular disease
•  The following physiological mechanisms are thought to play a role 
in facilitating the above mentioned health benefits:
 • Improvement in blood lipid concentrations9
 • Reduced systolic and diastolic blood pressure
 • Increased fibrinolysis
 • Reduced thrombocyte aggregation
 • Reduced endothelial dysfunction of the coronary arteries10 
 • Increased autonomic tone and heart rate variability
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 • Decreased cardiac arrythmias 11
 • Improvement of insulin resistance and glucose intolerance
 • Improved psychosocial factors
 • Improved lifestyle choices
 • Reduced obesity
 • Reduced smoking habit
 • Improved functional capacity
Due to the widespread acceptance of the importance of exercise 
rehabilitation in the secondary prevention of cardiovascular disease, 
a number of important position statements and guideline documents 
have been published by various medical associations. 12-17 
Practical considerations in prescribing exercise for the secondary 
prevention of chronic cardiovascular disease
The following are the main practical considerations with respect to 
exercise training in patients with cardiovascular disease: 
•  Prior to starting with regular exercise training all patients should be 
assessed by a cardiologist or medical practitioner skilled in exercise 
testing and prescription. Contraindications for exercise training in 
patients with cardiovascular disease should be excluded. (Table I).
Table I: Contraindications for exercise testing and training
1.  Unstable angina
2.  Resting systolic blood pressure > 200 mmHg
3.  Resting diastolic blood pressure > 110 mmHg
4.  Orthostatic blood pressure drop of > 20 mmHg with symptoms
5.  Critical aortic stenosis
6.  Acute systemic illness or fever
7.  Uncontrolled atrial or ventricular arrythmias
8.  Uncontrolled sinus tachycardia > 120 b/min
9.  Uncompensated cardiac failure
10.  3-degree heart block without a pacemaker
11.  Active pericarditis or myocarditis
12.  Recent embolism
13.  Thrombophlebitis
14.  Resting ST segment depression > 2 mm
15.  Uncontrolled diabetes
16.  Severe orthopaedic conditions that would prohibit exercise
17.   Other metabolic conditions including acute thyroiditis, hypokalaemia, 
hyperkalaemia, hypovolaemia etc
• Following exclusion of the above criteria, patients should undergo 
an exercise stress test in order for the practitioner to risk-stratify 
the patient. Medical supervision is suggested for moderate-to-
high-risk patients, e.g. those with exercise-induced myocardial 
ischaemia with possible ST-segment depression and/or angina 
pectoris and those with left ventricular ejection fraction < 30%, 
arrythmia, clinical depression, low exercise tolerance or those 
patients unaccustomed to exercise. Higher-risk patients are 
generally monitored more intensely and frequently than low-
risk patients. Risk stratification should be repeated at 3 month 
intervals.
• Exercise training programmes should be individualised and based 
on the patient’s initial test of functional capacity. 
• Tests of functional capacity should include an exercise stress 
electrocardiogram and a six-minute walk test. The six-minute walk 
test can be easily and inexpensively used to monitor the patient’s 
progress with respect to functional capacity. 
•  Exercise programming should include cardiovascular endurance, 
muscle strength, muscle endurance, flexibility and core stability 
exercises.  The programme should consist of a warm-up session, 
exercise training session and cool down.
•  The patient’s body composition and anthropometry should be 
measured before embarking on the programme and re-evaluated at 
6–12 week intervals.
•  Initiate the program at low level exercise and build up slowly, as 
tolerated, in very small increments.
•   Low-fit patients (functional capacity 5 METs) can often train at 
40–50% VO2 peak.  However, 70% of VO2 peak is appropriate for 
most low-moderate risk patients.
•  Monitor patients at each exercise session for abnormal signs 
and symptoms including chest pain or pressure, dizziness and 
arrythmia.  Telemetry monitoring can be used on higher risk 
patients.
•  High-intensity exercise may precipitate cardiovascular 
complications in post-MI patients.  Reserve high-intensity exercise 
for stable low-risk, fit patients.
• Log books with a patient’s attendance, medication changes, 
exercise frequency, intensity and duration, as well as recordable 
cardiovascular measurements, should be kept.  This alerts the 
practitioner to developing trends in signs and symptoms and 
enhances patient compliance.
• Patients should be encouraged to exercise at least three times a 
week for 30–40 minutes at a time. Condition specific exercises 
for orthopaedic conditions should also be included. As patients 
become fitter and become proficient with self-monitoring, 
additional home-based physical activity is prescribed for other 
days of the week. 
• Be aware of a sudden onset of exhaustion as well as insufficient 
recovery and overtraining.
• Complete emergency resuscitation facilities should be available at 
the exercise training venue. 
• When in doubt about progression of the exercise programme, 
increase in very small increments. Don’t encourage competition in 
the rehabilitation setting.
• Guidelines for progression from clinical or professional supervision 
to independent exercise are listed in Table II.
Table II:  Guidelines for the progression from clinical or professional supervision 
to independent exercise.
1.  Functional capacity twice the level of occupational demand
2.   Appropriate haemodynamic response to exercise (increasing systolic 
blood pressure with increasing work load) and recovery
3.   Appropriate ECG response at peak exercise with unchanged conduction, 
benign ischaemia (< 1 mm ST segment depression), stable or benign 
arrythmias
4.  Cardiac symptoms stable or absent
5.  Controlled baseline heart rate and blood pressure
6.  Patient has achieved adequate management of risk factors
7.   Patient has demonstrated knowledge of the disease process, abnormal 
signs and symptoms, medication use and side effects 
Not all patients are able to, or wish to participate in a supervised 
exercise rehabilitation programme. For these patients, home exercise 
rehabilitation should be encouraged as an alternative as it costs 
less and might be more convenient and perhaps would encourage 
independence and self-responsibility.     
With the advent of the data supporting physical activity in the 
management of chronic illness and the subsequent publication of 
official position stands and statements by numerous professional 
bodies advocating the use of physical exercise in the management 
strategies, so the growth of professionals in the field of exercise 
science and sports medicine has occurred.  Thus globally, sports 
physicians, physical therapists, biokineticists, exercise physiologists 
and athletic trainers have embraced this domain of intervention and 
 
                        
CPD Article
SA Fam Pract 2008                  Vol 50 No 59
from many postgraduate training programmes have emerged teaching 
specific techniques and approaches to chronic illness management.  
Indeed, at present there are pilot programmes to include aspects 
of exercise and positive lifestyle interventions in the undergraduate 
training of primary care doctors in various medical schools in South 
Africa. Thus, locally, many new programmes are increasingly being 
offered and the above discussion hopefully allows the practitioner to 
determine the quality of the various choices of programmes on offer.
Stress management
Understanding and addressing stress is an important and integral 
component of lifestyle modification in cardiac disease. The pervasive 
human experience of stress may be understood as a threat (real, 
implied or perceived) to homeostasis, and the integrated, multi-system 
mechanisms needed to maintain a stable internal milieu in the face 
of the perturbation. The stress response, while adaptive in the short 
term, can be deleterious when activated chronically, particularly 
in the face of psychological stressors where demands exceed the 
individual’s capacity to cope. Under conditions of chronic stress, an 
inefficient inactivation of stress-induced molecules results in cellular 
overexposure to these substances, which along with dysregulation of 
the autonomic nervous system, has pathophysiological consequences. 
18, 19
Psychological factors, including depression, anxiety, certain character 
traits, chronic life stress and unhealthy behaviours contribute 
significantly to the pathogenesis and expression of coronary artery 
disease,20while chronic stress, especially work stress, predicts 
cardiovascular morbidity and motility.21 Furthermore, managing a 
chronic condition, irrespective of aetiology, becomes its own stressor, 
whether it is related to compliance, undesired effects of poly-pharmacy, 
living with distressing symptoms, disruption to daily functioning or the 
emotional impact of recognising physical limitations or mortality. 
While there can be little argument as to the clinical significance 
of chronic psychological stress in chronic disease, and cardiac 
disease in particular, at the clinical interface it is a major challenge 
for family physicians and general practitioners to accurately assess 
the contribution of stress factors, in a time-limited consultation.  
Nonetheless evidence is increasingly clear that substantive stress 
reduction is an essential component of the long-term management 
of cardiac patients,22 and in this context, it is valuable for general 
practitioners to consider a separate follow-up appointment to deal with 
these issues directly. 
Whilst the assessment of stress utilising questionnaires including 
depression, anxiety and stress hardiness inventories are helpful 
if available, the practitioner should rely on a combination of skilful 
questioning and attentive listening, with primacy given to the subjective 
experience of the patient. Because psychological stress invariably 
involves a degree of vulnerability, the attitude of the clinician in creating 
a receptive and non-judgemental clinical environment will contribute 
significantly to the emergence of the necessary information. A basic 
evaluation of stress for the practitioner to use is presented in Table III.
Table III.   A basic clinical assessment of stress in patients with chronic 
cardiovascular disease.
•  Enquire directly if stress is a factor in the patient’s illness or a response 
to their living with a chronic disease (the simplest and most effective form 
of stress assessment)
•  Enquire directly if the patient has unhealthy behaviours (smoking, 
sedentary lifestyle, poor nutrition)
•  Determine the presence of other addictive behaviours: alcohol, drugs 
(prescription and illicit), food (comfort eating especially) and excessive 
spending, as evidence of reduced coping capacity
•  Enquire about symptoms of reactive or major depression, and anxiety 
(use of validated inventories is suggested)
•  Enquire directly regarding emotional and/or mental distress at the 
implication of having to live with a chronic disease. (Men are less likely to 
express emotional vulnerability).
•  Determine the presence of Emotional Reactivity: quick to anger, 
increased relational conflict both at work and at home
•  Determine the presence of stress-related symptoms including tension 
headaches, irritable bowel syndrome, disrupted sleep or fatigue (Men 
are more likely to somatise emotions than women)
Whilst the evidence-base of the role of stress and stress management 
in cardiac disease is fairly strong 23; there is no singular approach to 
managing stress in this clinical context. Because the contribution and 
consequence of stress is complex and idiosyncratic, each patient 
needs to be assessed and managed on their own merits. However 
it is useful for the practitioner to appreciate some of the overarching 
concepts of stress reduction which they can hold in mind as a 
contextual frame. The primary principle, most simply put, is that it is 
not the stress per se that is the problem, but how one responds to it. 
The patient, then, resides at the epicentre of their own stress reduction 
programme. The more aware, engaged and proactive the patient, 
the more the perception and sense of control is internalised and thus 
enhanced. 
There is thus no singular intervention in this regard; rather the 
practitioner should consider an integrated approach in which 
techniques and therapies are introduced either one by one, or in 
parallel. Suggestions for the practitioner to use for basic stress 
reduction are listed in Table IV.
Table IV:   Stress management options for patients with chronic cardiovascular 
disease 
General practitioner counselling: 
•   Attuned and non-judgmental listening for regular short sessions (6-8 
weeks)
•   Psychoeducation with relation to diet and smoking cessation emphasising 
the clinical significance of increased self-efficacy 
•   Direct counseling with relation to smoking cessation
Potential general practitioner stress intervention: 
•   Training to elicit the Relaxation Response: biofeedback, Benson’s 
relaxation response
Referral sources for stress reduction:
•  Addiction Support (AA, NA, CODA, SLAA)
•   Eliciting the Relaxation Response: biofeedback, meditation (Mindfulness, 
Trancendental Meditation), yoga (Hatha, Iyengar, Kundalini, Bikram), 
Tai’Chi
•  Mindfulness Based Stress Reduction (MBSR)
•   Mindfulness Based Cognitive Therapy to prevent depressive relapse 
(MBCT)
•   Psychotherapy (Cognitive Behavioural Therapy, Psychodynamic therapy, 
Jungian therapy)
The therapeutic aim should be for patients to enhance resilience, 
increase and optimise response flexibility, elicit the relaxation 
response regularly and to refine healthy self-regulation.  Furthermore, 
interpersonal stress both at home or at the workplace is a significant 
stressor. While connectedness is a significant buffer against stress-
related disorders, patients should be encouraged to address unhealthy 
or conflictual relational dynamics directly through the support of a 
counselor, therapist or coach.    
Dietary Intervention
There is evidence that indicates that the rising rate of coronary 
artery disease (CAD) can in part be attributed to the typical “Western 
diet” – heavy on salt, sugar and unhealthy fats. Indeed, as societies 
develop and become more westernised, poor lifestyle choices seem to 
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spread across the globe, increasing the health risk to populations for 
whom heart disease was never a major concern.24  Advising dietary 
change can significantly lower the risk of developing and assist in the 
management of patients with CAD and therefore this should form an 
important part of the intervention with patients who have CAD. 
General practitioners have an important role in advocating the 
nutritional changes necessary to manage patients with CAD. 
Progression of atherosclerosis is particularly affected by a diet high 
in saturated fat, trans fatty acids and dietary cholesterol. These 
compounds are found in many popular foods, including processed and 
“fast” foods, fatty cuts of meat, excessive use of eggs and full fat dairy 
products. General practitioners should advise their patients to adopt a 
diet aimed at maintaining LDL cholesterol concentrations low, and HDL 
cholesterol concentrations high.25, 26  Advice to patients in this respect 
would include the recommendations listed in Table V: 
Table V:  Practical dietary recommendations for lifestyle modification in patients 
with chronic cardiovascular disease27, 28
•  Consume a diet rich in fruits and vegetables
•   Increase the intake of whole-grain, high-fibre foods in preference to 
refined products (including white bread and white pasta)
•   Increase consumption of fish, especially oily fish, to at least twice a week
•   Minimise fat intake, and give preference to unsaturated fat particularly 
mono-unsaturated fat, and avoid saturated fats wherever possible. 
Eliminate trans-fats from the diet altogether. 
•   Reduce salt intake and advise moderate consumption of alcohol and 
increase consumption of potassium as this has been shown to lower 
blood pressure in patients with hypertension. 
•   Increase intake of antioxidants which lower inflammation. Antioxidant-
rich foods include red grapes, red wine, tea (especially green tea) and 
cocoa.  
•   Reduce intake of omega-6 fats and increase intake of omega-3 fats as 
this has been shown to reduce inflammation. Omega-3 fats are found 
in seeds (particularly flaxseeds), green leafy vegetables, nuts and fatty 
fish, while omega-6 fats are found in a range of some nuts, seeds, and 
oils. Fatty fish including salmon, mackerel, tuna and sardines are high in 
omega 3 fatty acids. If patients cannot eat at least two servings of fatty 
fish per week, omega 3 fish oil can be ingested as a supplement.
•   It is also important to control the intake of triglycerides which are 
associated with reduced HDL cholesterol concentrations. Excessive 
intake of alcohol, saturated and trans fat, sugar, refined starch and 
calories, particularly in addition to physical inactivity can result in an 
elevation of triglyceride concentrations
Maintenance of healthy body weight
As obesity is a major risk factor for chronic cardiovascular disease 
and diabetes, general practitioners can use the Body-Mass Index 
(BMI) as a tool to determine the level of weight-related risk. BMI can 
be calculated as weight/height.2  In general, the higher the BMI, the 
greater change a patient needs to institute to their diet and lifestyle 
in order to manage obesity, and chronic cardiovascular disease. A 
desired BMI is between 18.5-25. 
Elevated waist circumference is a sign of the metabolic syndrome 
and thus risk of progression of chronic cardiovascular disease. 
Global recommendations advocate a waist circumference of no 
more than 88cm for women and 102 cm for men.  These two 
abovementioned tools can be easily incorporated into the physical 
examination as they are not time consuming, and can be used 
not only to determine risk but can also be helpful in the ongoing 
monitoring of patients with chronic cardiovascular disease.
We advise the incorporation of the two measurement tools into the 
clinical evaluation of all patients. If there is limited time available 
during the consultation to discuss a healthy diet, suggest the 
abovementioned basic recommendations. A prepared patient hand-
out might be useful to reinforce these recommendations. If the 
patient requires more detail, remains overweight despite advice, or 
has other co-morbidities including diabetes, a formal referral to a 
dietician is important. 
Conclusion
This article has provided an overview of the basic lifestyle 
modifications to consider in the management of patients with chronic 
cardiovascular disease. A holistic view with respect to exercise 
training, dietary modification and adequate stress management 
approaches are all important in patient management. All patients 
should be afforded the time and interest of their general practitioner 
so that they may assist their patients in making good and well 
informed choices with respect to their lifestyle.   
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